- Home
- ACET vs FRD Comparison
ACET vs FRD Comparison
Compare ACET & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- FRD
- Stock Information
- Founded
- ACET 1947
- FRD 1965
- Country
- ACET United States
- FRD United States
- Employees
- ACET N/A
- FRD N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- FRD Steel/Iron Ore
- Sector
- ACET Health Care
- FRD Industrials
- Exchange
- ACET Nasdaq
- FRD Nasdaq
- Market Cap
- ACET 93.1M
- FRD 99.3M
- IPO Year
- ACET N/A
- FRD N/A
- Fundamental
- Price
- ACET $0.96
- FRD $15.52
- Analyst Decision
- ACET Strong Buy
- FRD
- Analyst Count
- ACET 4
- FRD 0
- Target Price
- ACET $5.67
- FRD N/A
- AVG Volume (30 Days)
- ACET 790.0K
- FRD 11.9K
- Earning Date
- ACET 11-06-2024
- FRD 11-12-2024
- Dividend Yield
- ACET N/A
- FRD 1.04%
- EPS Growth
- ACET N/A
- FRD N/A
- EPS
- ACET N/A
- FRD 1.14
- Revenue
- ACET N/A
- FRD $469,515,000.00
- Revenue This Year
- ACET N/A
- FRD N/A
- Revenue Next Year
- ACET N/A
- FRD N/A
- P/E Ratio
- ACET N/A
- FRD $13.62
- Revenue Growth
- ACET N/A
- FRD N/A
- 52 Week Low
- ACET $0.89
- FRD $13.40
- 52 Week High
- ACET $3.77
- FRD $19.52
- Technical
- Relative Strength Index (RSI)
- ACET 37.36
- FRD 48.88
- Support Level
- ACET $0.91
- FRD $15.77
- Resistance Level
- ACET $1.12
- FRD $18.01
- Average True Range (ATR)
- ACET 0.09
- FRD 0.86
- MACD
- ACET 0.00
- FRD -0.12
- Stochastic Oscillator
- ACET 16.21
- FRD 23.51
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.